These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30760241)

  • 21. Impact of cannabidiol-rich hemp extract oil on reconsolidation disruption of naturalistic interoceptive aversive memory in humans: Protocol for a randomized clinical trial.
    Zaizar ED; Papini S; O'Connor P; Telch MJ
    Contemp Clin Trials; 2022 Aug; 119():106847. PubMed ID: 35811050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
    Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
    Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials.
    Müller AR; den Hollander B; van de Ven PM; Roes KCB; Geertjens L; Bruining H; van Karnebeek CDM; Jansen FE; de Wit MCY; Ten Hoopen LW; Rietman AB; Dierckx B; Wijburg FA; Boot E; Brands MMG; van Eeghen AM
    BMC Psychiatry; 2024 Jan; 24(1):23. PubMed ID: 38177999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treating specific childhood phobia in a single session? A systematic review of the literature].
    Fond G; Franc N
    Encephale; 2013 Apr; 39(2):109-14. PubMed ID: 23095586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of cannabidiol in anxiety and anxiety-related disorders.
    Skelley JW; Deas CM; Curren Z; Ennis J
    J Am Pharm Assoc (2003); 2020; 60(1):253-261. PubMed ID: 31866386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
    Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
    Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does cannabidiol reduce severe behavioural problems in children with intellectual disability? Study protocol for a pilot single-site phase I/II randomised placebo controlled trial.
    Efron D; Taylor K; Payne JM; Freeman JL; Cranswick N; Mulraney M; Prakash C; Lee KJ; Williams K
    BMJ Open; 2020 Mar; 10(3):e034362. PubMed ID: 32152170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
    Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
    JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response.
    Acheson DT; Feifel D; Kamenski M; Mckinney R; Risbrough VB
    Depress Anxiety; 2015 Jun; 32(6):400-7. PubMed ID: 25826649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer-aided vs. tutor-delivered teaching of exposure therapy for phobia/panic: randomized controlled trial with pre-registration nursing students.
    Gega L; Norman IJ; Marks IM
    Int J Nurs Stud; 2007 Mar; 44(3):397-405. PubMed ID: 16631177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of an Internet-based intervention with self-applied exposure therapy in virtual reality for people with panic disorder: study protocol for a randomized controlled trial.
    Schultz J; Baumeister A; Schmotz S; Moritz S; Jelinek L
    Trials; 2023 Aug; 24(1):521. PubMed ID: 37573377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).
    Mersiades AJ; Tognela A; Haber PS; Stockler M; Lintzeris N; Simes J; McGregor I; Olver I; Allsop DJ; Gedye C; Kirby AC; Morton RL; Fox P; Clarke S; Briscoe K; Aghmesheh M; Wong N; Walsh A; Hahn C; Grimison P
    BMJ Open; 2018 Sep; 8(9):e020745. PubMed ID: 30209152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eye movement desensitization and reprocessing (EMDR) therapy or supportive counseling prior to exposure therapy in patients with panic disorder: study protocol for a multicenter randomized controlled trial (IMPROVE).
    Endhoven B; De Cort K; Matthijssen SJMA; de Jongh A; van Minnen A; Duits P; Schruers KRJ; van Dis EAM; Krypotos AM; Gerritsen L; Engelhard IM
    BMC Psychiatry; 2023 Mar; 23(1):157. PubMed ID: 36918861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
    Pyrkosch L; Mumm J; Alt I; Fehm L; Fydrich T; Plag J; Ströhle A
    J Psychiatr Res; 2018 Oct; 105():153-163. PubMed ID: 30237105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabidiol as a Treatment for Neurobiological, Behavioral, and Psychological Symptoms in Early-Stage Dementia: A Double-Blind, Placebo-Controlled Clinical Trial Protocol.
    Bartschi JG; Greenwood LM; Montgomery A; Dortants L; Weston-Green K; Huang XF; Pai N; Potter J; Schira MM; Croft R; Solowij N
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):348-359. PubMed ID: 36040362
    [No Abstract]   [Full Text] [Related]  

  • 38. Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing.
    Narayan AJ; Downey LA; Rose S; Di Natale L; Hayley AC
    J Clin Sleep Med; 2024 May; 20(5):753-763. PubMed ID: 38174873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans.
    Bergmans RS; Wegryn-Jones R; Klida C; Kurtz V; Thomas L; Williams DA; Clauw DJ; Kidwell KM; Bohnert ASB; Boehnke KF
    BMC Complement Med Ther; 2024 Jun; 24(1):250. PubMed ID: 38951902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 0Phobia - towards a virtual cure for acrophobia: study protocol for a randomized controlled trial.
    Donker T; Van Esveld S; Fischer N; Van Straten A
    Trials; 2018 Aug; 19(1):433. PubMed ID: 30092844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.